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Avian Influenza Vaccination
Sherrill Davison, V M.D" Phillip Scott,
Ph. D., and Robert 1. Eckroade, D. VM.
vian Influenza (AI) is a v iral res
piratory diseuse of many species
of domestic and wild birds. His
torically, in commerci a l poultry flocks,
turkeys are most co mmonly affected due
to the practice of range rearing and co
mingling with wild birds . While only six
outbreaks of Al ha ve occurred in com
mercial chickens in the U nited States
prior to the current 1997 outbreak , when
they occur they can be devastating. The
1983-1984 AI outbreak in Pe nnsylvania
resulted in the depop ulation of 17 mil
lion birds with a cost to the fed eral gov
ern me nt of $60 millio n .
T he rece nt AI outbreak in Pennsylvania
began in December 1996 whe n a live bird
market dealer's /lock in Lebanon County
was found to b positi ve for nonpathogenic
AI (H7 N2). Subseq uent to that, a flock of

A

commercial layers in the same vicinity was
diagnosed with nonpathogenic AI (H7N2).
Then in April 1997, a flock of commercial
layers was diagnosed with AI in Lancaster
County. A quarantine was placed on poul
try facilities in a five mile radius of the in
dex tlock in Lancaster County. To date, a
total of 19 commercial layer flocks, two
commercial layer pullet tlocks, and a com
mercial meat turkey flock have been diag
nosed with non-pathogenic AI (H7N2)
viral infection.
Control of avian influenza includes
depopulation , quarantine and vaccina
tion. Research and field experience
(Mexico and the United States) has
shown that vaccination for avian influ
enza can decrease the clinical signs of
avian influenza, decrease the viral shed
from known infected birds and therefore
decrease the potential transmission of the
disease to surrounding flocks.
Avian influenza vaccination has not

Identification ofgene defect leads to cystinuria test
The gene de fect for cystinuria in
Newfou ndlands has been identified by
Dr. Pau la He nthorn, u. ociate professor
of medical genetics, and co lleagues in
the Section of Medical Ge netics at
Penn 's School of Veterinary Medicine.
The team , whic h includes Dr' . Urs
G iger and Jung Long Lin . has deve l
oped a test t ide ntify carriers, affected.
and normal dogs fo r the d isease in e w
foundlands . Cyst inuria, which also af
fects many other breeds. is an
autosomal recessive trait.
The molecular te t is the sixth such
test the Penn grou p has developed. New
foundland breeders can now screen their
br eding stock fo r thi . disease to reduce
the numher of affe tcd animals. If all
breeding animals are screened, the dis
ease can be elimi nated from the New
foundland population in the relatively
short period or nne to two generations.
Cystinuria is caus d by excessive
urinary excreti on J[' c stine and other
amino acids due to a defective trans port
system for these ~ubs t ances in the kid
ney. It leads to cry stal and eventual
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stone (bladder and kidney stones) for
mation in the urinary tract and is par
ticularly problematic in male dogs.
Dr. Henthorn and her colleagues are
now working to identify the gene de
fects causing cystinuria in other affected
breeds so that additional tests can be de
veloped. Unfortunately, in genetic dis
ea 'e ', the gene defect ~ r a di sease and
its location vary from breed to breed,
requi ring much painstaking research to
develop tests for each breed.
Dr. Henthorn's work On cystinuria i:
supported by grants from the National
Institutes of Health and the AKC Ca
nine Health Foundation. The test for
cystinuria in Newfoundlands is one of
the many tests for canine and feline ge
netic diseases available through the
Josephine Deubler Genetic Disease
Testing Laboratory in the Section of
Medical Genetics, School of Veterinary
Medicine, University of Pennsylvania.
For additional information, contact Dr.
rs Giger at 215-898-3375(phone),
21 5-573-2162 (fax) or via e-mail
at<penngen@vet.upenn.edu>.

been approved for use in the United States
in chickens unless the virus is highly
pathogenic. The use of vaccine in Penn
sylvania during the 1997 avian influenza
outbreak was denied because the virus
was classified as nonpathogenic. Cur
rently, the only available vaccine for use
in commercial pOUltry is a killed product.
Additional vaccines under development
are the fowl pox viral vectored vaccine
and sub-unit protein vaccines.
Major advances in our understanding of
vaccines have occurred due to basic mo
lecular studies, and are currently being ap
plied to the improvement of vaccines
against many human diseases. One of the
most exciting advances in the development
of new vaccines has been the discovery
that injection of DNA-encoding viral anti
gens that are known to be protective - can
induce protection that is equivalent to, or
superior to, that obtained following immu
nization with killed whole organisms, puri
fied proteins, or subunit vaccines.
There are several notable advantages to
using DNA vaccines over conventional pro
tein antigens, some of which include: 1) the
ease of manufacturing the vaccine; 2) the sta
bility of the vaccine; 3) providing long-term
antigen expression that continuously stimu
lates the immune response; 4) the lack of a
requirement for a traditional adjuvant; 5) the
ability of DNA vaccines to stimulate both
strong antibody responses, T cell responses
and the generation of cytotoxic T cells; and 6)
the ability to co-deliver the vaccine with pJas
rnid-DNA-encoding cytokines to enhance the
immune response. Of particular interest has
been the inclusion of cytokines, one of the
most important of which is interleukin-12
(lL-12) which, when administered in a vac
cine, dramatically improves the efficacy. U n
fortunately, these advances have been slow to
be applied to food animals, where they could
make a major impact in the agricultural in
dustry. Our research wLll focus on the devel
opment of a molecularly defmed avian
influenza vaccine that incorporates IL-12,
and compare the efficacy of such a vaccine
with a commercially available killed vaccine.
Development of a ON A vaccine will provide
the basic information and tools necessary to
offer the poultry industry of Pennsylvania the
most effective vaccine available against avian
influenza.

